Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

Claus F. Vogelmeier; Gerard J. Criner; Fernando J. Martinez; Antonio Anzueto; Peter J. Barnes; Jean Bourbeau; Bartolome R. Celli; Rongchang Chen; Marc Decramer; Leonardo M. Fabbri; Peter Frith; David M.G. Halpin; M. Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D. Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A. Wedzicha; Alvar Agusti

doi:10.1111/resp.13012

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen VestboJadwiga A. Wedzicha, Alvar Agusti

Division of Pulmonary Diseases

Research output: Contribution to journal › Article › peer-review

293 Scopus citations

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

Original language	English (US)
Pages (from-to)	575-601
Number of pages	27
Journal	Respirology
Volume	22
Issue number	3
DOIs	https://doi.org/10.1111/resp.13012
State	Published - Apr 1 2017

Keywords

COPD diagnosis
COPD management
COPD prevention
chronic obstructive pulmonary disease

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1111/resp.13012

Cite this

Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., ... Agusti, A. (2017). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Respirology, 22(3), 575-601. https://doi.org/10.1111/resp.13012

Vogelmeier, CF, Criner, GJ, Martinez, FJ, Anzueto, A, Barnes, PJ, Bourbeau, J, Celli, BR, Chen, R, Decramer, M, Fabbri, LM, Frith, P, Halpin, DMG, López Varela, MV, Nishimura, M, Roche, N, Rodriguez-Roisin, R, Sin, DD, Singh, D, Stockley, R, Vestbo, J, Wedzicha, JA & Agusti, A 2017, 'Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary', Respirology, vol. 22, no. 3, pp. 575-601. https://doi.org/10.1111/resp.13012

@article{2a2119eadcbc4522825cc73bc21780f7,

title = "Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary",

abstract = "This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.",

keywords = "COPD diagnosis, COPD management, COPD prevention, chronic obstructive pulmonary disease",

author = "Vogelmeier, {Claus F.} and Criner, {Gerard J.} and Martinez, {Fernando J.} and Antonio Anzueto and Barnes, {Peter J.} and Jean Bourbeau and Celli, {Bartolome R.} and Rongchang Chen and Marc Decramer and Fabbri, {Leonardo M.} and Peter Frith and Halpin, {David M.G.} and {L{\'o}pez Varela}, {M. Victorina} and Masaharu Nishimura and Nicolas Roche and Roberto Rodriguez-Roisin and Sin, {Don D.} and Dave Singh and Robert Stockley and J{\o}rgen Vestbo and Wedzicha, {Jadwiga A.} and Alvar Agusti",

note = "Publisher Copyright: {\textcopyright} 2017 The American Thoracic Society. Published with permission from the American Thoracic Society",

year = "2017",

month = apr,

day = "1",

doi = "10.1111/resp.13012",

language = "English (US)",

volume = "22",

pages = "575--601",

journal = "Respirology",

issn = "1323-7799",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report

T2 - GOLD Executive Summary

AU - Vogelmeier, Claus F.

AU - Criner, Gerard J.

AU - Martinez, Fernando J.

AU - Anzueto, Antonio

AU - Barnes, Peter J.

AU - Bourbeau, Jean

AU - Celli, Bartolome R.

AU - Chen, Rongchang

AU - Decramer, Marc

AU - Fabbri, Leonardo M.

AU - Frith, Peter

AU - Halpin, David M.G.

AU - López Varela, M. Victorina

AU - Nishimura, Masaharu

AU - Roche, Nicolas

AU - Rodriguez-Roisin, Roberto

AU - Sin, Don D.

AU - Singh, Dave

AU - Stockley, Robert

AU - Vestbo, Jørgen

AU - Wedzicha, Jadwiga A.

AU - Agusti, Alvar

PY - 2017/4/1

Y1 - 2017/4/1

N2 - This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

AB - This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

KW - COPD diagnosis

KW - COPD management

KW - COPD prevention

KW - chronic obstructive pulmonary disease

UR - http://www.scopus.com/inward/record.url?scp=85014597265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014597265&partnerID=8YFLogxK

U2 - 10.1111/resp.13012

DO - 10.1111/resp.13012

M3 - Article

C2 - 28150362

AN - SCOPUS:85014597265

SN - 1323-7799

VL - 22

SP - 575

EP - 601

JO - Respirology

JF - Respirology

IS - 3

ER -

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this